|
|
|
|
|
|
|
|
Job Security in a Changing Biopharma Environment
|
|
|
| By
Amy Ritter, PhD
|
|
|
|
Results from the 2012 employment survey.
|
|
|
|
Optimizing Global Biopharmaceutical Operations Through Risk Mitigation and Management
|
|
|
| By
Phil Kaminsky
,
Jiyang Liu
,
Julia Olsen-Claire
|
|
|
|
A UC Berkeley survey provides insight into biopharma's risk concerns and strategies.
|
|
|
|
Navigating Emerging Markets
|
|
|
| By
Jill E. Sackman, PhD
|
|
|
|
An introduction to a new series on manufacturing within global markets.
|
|
|
|
A New Scale-Down Membrane Adsorber Device for Process Development and Validation
|
|
|
| By
Nathalie Frau, PhD
,
Martin Leuthold, PhD
,
Amit Mehta, PhD
,
Kome (Kevin) Shomglin, PhD
,
Rene Faber, PhD
|
|
|
|
The authors describe the development of an ultra scale-down anion exchange membrane adsorber, and demonstrate scalability to larger-scale devices.
|
|
|
|
Closures for Pharmaceutical Preparations: A Review of Design and Test Considerations
|
|
|
| By
Tim Sandle, PhD
|
|
|
|
The author examines the use of closures for products intended for injection.
|
|
|
|
A 25-Year Retrospective on Computer System Validation
|
|
|
| By
Sharon Strause
|
|
|
|
This month, Sharon Strause, an industry consultant, provides a look back at "Computer System Validation Part I: Testing and Verification of Applications Software" by Leonard J. Goren.
|
|
|
|
|
|
|
|
|
When Disaster Strikes at Home
|
|
|
| By
Angie Drakulich
|
|
|
|
Keeping tabs on crucial medicines should be part of consumers' and manufacturers' emergency-preparedness plans.
|
|
|
|
|
|
|
|
|
Discovery Pipeline: Understanding Cellular Reprogramming
|
|
|
| By
Amy Ritter, PhD
|
|
|
|
Recent research examines the sequence of events underlying cellular reprogramming, which may aid in better control of the production of induced pluripotent stem cells.
|
|
|
|
Report from South Korea
|
|
|
| By
Jane Wan
|
|
|
|
The South Korean market is characterized by its aging population and an affluent population. Growth potential is limited as it has evolved to a developed market and industry players expect it to have established regulations.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
